SAHELI the world's first non-steroidal oral contraceptive pill is developed by the Central Drug Research Institute of India, Lucknow after over two decades of research.

Unique and convenient dosage:

Only twice a week for the first three months. Subsequently only once a week.

Extensive clinical data available for registration with drug control authorities.

Devoid of the side effects normally associated with conventional steroid based pills.

Production strictly in line with WHO GMP norms.